Manufacturers Life Insurance Company, The Lexicon Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 48,048 shares of LXRX stock, worth $34,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,048
Previous 49,957 3.82%
Holding current value
$34,114
Previous $83,000 9.64%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1.51 - $2.39 $2,882 - $4,562
-1,909 Reduced 3.82%
48,048 $75,000
Q2 2024

Aug 14, 2024
BUY
$1.54 - $2.28 $22,192 - $32,857
14,411 Added 40.54%
49,957 $83,000
Q1 2024

May 14, 2024
BUY
$1.3 - $3.58 $22,523 - $62,027
17,326 Added 95.09%
35,546 $85,000
Q4 2023

Feb 13, 2024
SELL
$1.0 - $1.53 $24,267 - $37,128
-24,267 Reduced 57.12%
18,220 $27,000
Q3 2023

Nov 15, 2023
BUY
$1.06 - $2.33 $1,398 - $3,073
1,319 Added 3.2%
42,487 $46,000
Q2 2023

Aug 11, 2023
BUY
$2.15 - $3.49 $11,233 - $18,235
5,225 Added 14.54%
41,168 $94,000
Q4 2022

Aug 11, 2023
BUY
$1.8 - $2.56 $36,117 - $51,366
20,065 Added 126.37%
35,943 $68,000
Q4 2022

Feb 13, 2023
BUY
$1.8 - $2.56 $36,117 - $51,366
20,065 Added 126.37%
35,943 $68,000
Q3 2022

Aug 11, 2023
SELL
$1.94 - $3.43 $34,630 - $61,228
-17,851 Reduced 52.92%
15,878 $38,000
Q3 2022

Nov 03, 2022
BUY
$1.94 - $3.43 $30,803 - $54,461
15,878 New
15,878 $38,000
Q2 2022

Aug 15, 2022
SELL
$1.31 - $2.69 $44,184 - $90,731
-33,729 Closed
0 $0
Q1 2022

Aug 11, 2023
SELL
$1.95 - $3.89 $4,317 - $8,612
-2,214 Reduced 6.16%
33,729 $70,000
Q1 2022

May 20, 2022
SELL
$1.95 - $3.89 $10,941 - $21,826
-5,611 Reduced 14.26%
33,729 $70,000
Q4 2021

Feb 16, 2022
BUY
$3.81 - $6.16 $1,028 - $1,663
270 Added 0.69%
39,340 $155,000
Q3 2021

Nov 12, 2021
SELL
$3.38 - $5.35 $8,297 - $13,134
-2,455 Reduced 5.91%
39,070 $188,000
Q2 2021

Aug 12, 2021
BUY
$4.12 - $5.87 $41,822 - $59,586
10,151 Added 32.35%
41,525 $191,000
Q1 2021

May 03, 2021
SELL
$3.45 - $9.09 $1,618 - $4,263
-469 Reduced 1.47%
31,374 $184,000
Q4 2020

Feb 12, 2021
BUY
$1.05 - $3.67 $33,435 - $116,863
31,843 New
31,843 $109,000
Q2 2020

Aug 10, 2020
SELL
$1.75 - $2.3 $54,684 - $71,870
-31,248 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$1.8 - $4.28 $4,312 - $10,254
2,396 Added 8.3%
31,248 $61,000
Q4 2019

Feb 14, 2020
SELL
$3.16 - $5.15 $5,046 - $8,224
-1,597 Reduced 5.24%
28,852 $120,000
Q3 2019

Nov 12, 2019
BUY
$1.2 - $6.66 $415 - $2,304
346 Added 1.15%
30,449 $105,000
Q2 2019

Aug 14, 2019
SELL
$5.35 - $7.11 $10,951 - $14,554
-2,047 Reduced 6.37%
30,103 $189,000
Q1 2019

May 13, 2019
BUY
$4.36 - $7.94 $13,912 - $25,336
3,191 Added 11.02%
32,150 $179,000
Q4 2018

Feb 14, 2019
SELL
$6.15 - $10.51 $19,464 - $33,264
-3,165 Reduced 9.85%
28,959 $192,000
Q3 2018

Nov 14, 2018
SELL
$10.32 - $13.06 $38,039 - $48,139
-3,686 Reduced 10.29%
32,124 $343,000
Q2 2018

Aug 14, 2018
SELL
$7.8 - $13.69 $2,909 - $5,106
-373 Reduced 1.03%
35,810 $430,000
Q1 2018

May 15, 2018
BUY
$7.86 - $11.39 $974 - $1,412
124 Added 0.34%
36,183 $310,000
Q4 2017

Feb 08, 2018
BUY
$8.77 - $12.28 $5,805 - $8,129
662 Added 1.87%
36,059 $356,000
Q3 2017

Nov 14, 2017
BUY
$12.17 - $16.3 $430,781 - $576,971
35,397
35,397 $436,000

Others Institutions Holding LXRX

# of Institutions
141
Shares Held
238M
Call Options Held
459K
Put Options Held
133K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email